POSITRON EMISSION TOMOGRAPHY AND CT SCAN IN PREDICTING RESPONSE IN PATIENTS WITH METASTATIC MELANOMA OR KIDNEY CANCER WHO ARE UNDERGOING CELLULAR ADOPTIVE IMMUNOTHERAPY ON A SURGERY BRANCH CLINICAL TRIAL: